Development of pyrrolo[2,1-c][1,4]benzodiazepine β-glucoside prodrugs for selective therapy of cancer.

[1]  I. Zupkó,et al.  Synthesis and investigation of the anticancer effects of estrone-16-oxime ethers in vitro , 2013, Steroids.

[2]  R. Rocha,et al.  CLINICS 2011;66(6):965-972 DOI:10.1590/S1807-59322011000600008 CLINICAL SCIENCE , 2022 .

[3]  L. Tietze,et al.  Antibody‐Directed Enzyme Prodrug Therapy: A Promising Approach for a Selective Treatment of Cancer Based on Prodrugs and Monoclonal Antibodies , 2009, Chemical biology & drug design.

[4]  A. Kamal,et al.  Pyrrolo[2,1-c][1,4]benzodiazepine-beta-glucuronide prodrugs with a potential for selective therapy of solid tumors by PMT and ADEPT strategies. , 2008, Bioorganic & medicinal chemistry letters.

[5]  U. Bhadra,et al.  Development of Pyrrolo[2,1‐c][1,4]benzodiazepine β‐Galactoside Prodrugs for Selective Therapy of Cancer by ADEPT and PMT , 2008, ChemMedChem.

[6]  V. Buchta,et al.  New targeting system for antimycotic drugs: beta-glucosidase sensitive amphotericin B-star poly(ethylene glycol) conjugate. , 2008, Bioorganic & medicinal chemistry letters.

[7]  Tycho Heimbach,et al.  Prodrugs: design and clinical applications , 2008, Nature Reviews Drug Discovery.

[8]  M. Botta,et al.  Synthesis and biological evaluation of new taxoids derived from 2-deacetoxytaxinine J. , 2007, Bioorganic & medicinal chemistry letters.

[9]  K. Bagshawe.  Antibody-directed enzyme prodrug therapy (ADEPT) for cancer , 2006, Expert review of anticancer therapy.

[10]  R. Begent,et al.  Synthesis and biological evaluation of novel pyrrolo[2,1-c][1,4]benzodiazepine prodrugs for use in antibody-directed enzyme prodrug therapy. , 2006, Bioorganic & medicinal chemistry letters.

[11]  D. Thurston,et al.  The Chemotherapy of Cancer , 2005 .

[12]  P. Wang,et al.  Synthesis and enzyme-specific activation of carbohydrate-geldanamycin conjugates with potent anticancer activity. , 2005, Journal of medicinal chemistry.

[13]  W. Denny.  Tumor-activated Prodrugs—A New Approach to Cancer Therapy , 2004, Cancer investigation.

[14]  L. Tietze,et al.  Enzyme and proton-activated prodrugs for a selective cancer therapy. , 2003, Current pharmaceutical design.

[15]  L. Tietze,et al.  Review: Highly Selective Compounds for the Antibody-Directed Enzyme Prodrug Therapy of Cancer , 2003 .

[16]  A. Kamal,et al.  Design, synthesis, and evaluation of new noncross-linking pyrrolobenzodiazepine dimers with efficient DNA binding ability and potent antitumor activity. , 2002, Journal of medicinal chemistry.

[17]  P. Burke,et al.  Design and synthesis of novel pyrrolobenzodiazepine (PBD) prodrugs for ADEPT and GDEPT. , 2000, Bioorganic & medicinal chemistry letters.

[18]  R. Knox,et al.  Enzyme-Prodrug Strategies for Cancer Therapy , 1999, Springer US.

[19]  A. Photiou,et al.  Antibody-directed enzyme prodrug therapy (ADEPT). , 1996, International journal of oncology.

[20]  D. Thurston,et al.  A new convenient procedure for the synthesis of pyrrolo[2,1-c][l,4]benzodiazepines , 1993 .

[21]  D. Kerr,et al.  Generation of cytotoxic agents by targeted enzymes. , 1993, Bioconjugate chemistry.

[22]  R. Shigemoto,et al.  Distribution of the glucose transporters in human brain tumors. , 1992, Cancer research.

[23]  D. Thurston,et al.  New approaches to pyrrolo[2,1-c][1,4]benzodiazepines: synthesis, DNA-binding and cytotoxicity of DC-81. , 1992, Tetrahedron.

[24]  M. Barkley,et al.  Characterization of a unique tomaymycin-d(CICGAATTCICG)2 adduct containing two drug molecules per duplex by NMR, fluorescence, and molecular modeling studies. , 1990, Biochemistry.

[25]  P. Senter.  Activation of prodrugs by antibody‐enzyme conjugates: a new approach to cancer therapy , 1990, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[26]  C. Springer,et al.  A cytotoxic agent can be generated selectively at cancer sites. , 1988, British Journal of Cancer.

[27]  J. R. Hoover,et al.  Pyrrolo[1,4]benzodiazepine antitumor antibiotics: relationship of DNA alkylation and sequence specificity to the biological activity of natural and synthetic compounds. , 1988, Chemical research in toxicology.

[28]  K. D. Bagshawe,et al.  Antibody directed enzymes revive anti-cancer prodrugs concept. , 1987, British Journal of Cancer.

[29]  D. Langley,et al.  A versatile and efficient synthesis of carbinolamine-containing pyrrolo[1,4]benzodiazepines via the cyclization of N-(2-aminobenzoyl)pyrrolidine-2-carboxaldehyde diethyl thioacetals: total synthesis of prothracarcin , 1987 .

[30]  T. Krugh,et al.  The reaction of anthramycin with DNA. Proton and carbon nuclear magnetic resonance studies on the structure of the anthramycin-DNA adduct. , 1984, The Journal of biological chemistry.

[31]  D. J. Kaplan,et al.  Pyrrol[1,4]benzodiazepine antibiotics. Proposed structures and characteristics of the in vitro deoxyribonucleic acid adducts of anthramycin, tomaymycin, sibiromycin, and neothramycins A and B. , 1981, Biochemistry.

[32]  L. Hurley,et al.  Proposed structure of the anthramycin–DNA adduct , 1979, Nature.